Social media use and influenza vaccine uptake among White and African American adults

Vaccine. 2018 Nov 26;36(49):7556-7561. doi: 10.1016/j.vaccine.2018.10.049. Epub 2018 Oct 30.

Abstract

Influenza vaccination rates in the U.S. remain low at 41% among adults over 18 years according to the Centers for Disease Control and Prevention's 2016 data. Reasons for the low rate vary and include factors such as risk perception, vaccine hesitancy, and access to health care. This cross-sectional study sought to examine the relationship between social media use and influenza vaccine uptake among a sample of White and African Americans over 18 years of age. Using bivariate, and unadjusted and adjusted logistic regression tests, this study examined the relationship among social media use, social media as a source of health information, and influenza vaccination status in 2015. Our results indicate that users of Twitter (OR4.41, 95%CI: 1.43-13.60) and Facebook (OR 1.66, 95%CI: 1.01-2.72) as sources of health information were more likely to be vaccinated in comparison to users who do not use Twitter or Facebook as a source of health information. These findings have implications for the potential of using social media platforms to disseminate influenza vaccine information and encourage users to get vaccinated annually.

Keywords: Digital health; Facebook; Health information sources; Twitter.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Black or African American
  • Consumer Health Information
  • Cross-Sectional Studies
  • Female
  • Health Knowledge, Attitudes, Practice / ethnology*
  • Humans
  • Influenza Vaccines / administration & dosage*
  • Influenza, Human / prevention & control
  • Male
  • Middle Aged
  • Patient Acceptance of Health Care / ethnology*
  • Patient Acceptance of Health Care / psychology
  • Social Media*
  • Surveys and Questionnaires
  • United States
  • Vaccination Coverage / statistics & numerical data*
  • White People
  • Young Adult

Substances

  • Influenza Vaccines